New Issue: Helix BioMedix raises $2.32 million in private placement of stock

By Sheri Kasprzak

Atlanta, March 1 - Helix BioMedix said it has closed a private placement of stock for $2,322,750.

The company sold 1,548,500 shares at $1.50 each.

The investors in the offering also received warrants for up to 125,000 shares, exercisable at $1.50 each for five years.

Based in Bothell, Wash., Helix is a biotechnology company focused on developing and commercializing bioactive peptides for use as anti-infectives. The proceeds will be used for working capital and to further the development of the peptides.

Issuer:	Helix BioMedix
Issue:	Stock
Amount:	$2,322,750
Shares:	1,548,500
Price:	$1.50
Warrants:	For 125,000 shares
Warrant expiration:	Five years
Warrant strike price:	$1.50
Settlement date:	Feb. 28
Stock price:	$1.70 at close Feb. 28

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.